hábit Labs · Devolve Corp
Certificate of Analysis
For research purposes only. This material is supplied for in-vitro laboratory research by qualified researchers. It shall not be used for human therapeutic purposes and is not for human or veterinary consumption. It is not a drug, supplement, cosmetic, food additive, or medical device.
Product identification
ProductTesamorelin 10mg
DescriptionStabilized GHRH(1-44) analog
Lot numberHB2-20260921-KG9Q-01
Release date24 Sep 2026
Molecular formulaC₂₂₁H₃₆₆N₇₂O₆₇S
AppearanceLyophilized powder
Storage−20 °C, protected from light
ManufacturerDevolve Corp d/b/a hábit · Ft. Lauderdale, FL
Analytical results
Purity (HPLC)98.03%✓ Conforms
Content / vial10.33 mg (103.3% of label claim 10 mg)✓ Conforms
Identity (HPLC RT + UV)Tesamorelin✓ Conforms
AppearanceWhite lyophilized powder✓ Conforms
Purity spec≥ 95.0% (HPLC area %)
Content spec≥ 90% of label claim
Scope: identity, chromatographic purity, net peptide content per vial and appearance. Chromatographic purity is the share of detected material that is the target peptide; it is not net peptide mass, which is reported separately as content per vial. Endotoxin, sterility, microbial, heavy-metal and residual-solvent testing are not part of this certificate.
Specifications
CAS218949-48-5
Molecular formulaC₂₂₁H₃₆₆N₇₂O₆₇S
Molecular weight5,135.9 g/mol
FormLyophilized
Purity98.03% by HPLC (lot HB2-20260921-KG9Q)
Available dosages10mg
Current lotHB2-20260921-KG9Q
Storage & handling
Lyophilized: −20°C, 24 months. Reconstituted: 2–8°C, use within 14 days — like other GHRH analogs, tesamorelin is more stable lyophilized than in solution. Reconstitute with bacteriostatic water; protect from light.